economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/articleshow/53407488.cms

Preview meta tags from the economictimes.indiatimes.com website.

Linked Hostnames

25

Thumbnail

Search Engine Appearance

Google

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/articleshow/53407488.cms

US’ Gilead faces competition from Bangladesh’s Beacon pharma

The challenger Beacon produces first generic version of Gileads newly launched Epclusa — a drug used to treat all types of Hepatitis C.



Bing

US’ Gilead faces competition from Bangladesh’s Beacon pharma

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/articleshow/53407488.cms

The challenger Beacon produces first generic version of Gileads newly launched Epclusa — a drug used to treat all types of Hepatitis C.



DuckDuckGo

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/articleshow/53407488.cms

US’ Gilead faces competition from Bangladesh’s Beacon pharma

The challenger Beacon produces first generic version of Gileads newly launched Epclusa — a drug used to treat all types of Hepatitis C.

  • General Meta Tags

    27
    • title
      US’ Gilead faces competition from Bangladesh’s Beacon pharma - The Economic Times
    • Content-Type
      text/html; charset=UTF-8
    • description
      The challenger Beacon produces first generic version of Gileads newly launched Epclusa — a drug used to treat all types of Hepatitis C.
    • news_keywords
      Bangladesh,USFDA,Hepatitis C,Beacon,Gilead
    • keywords
      Bangladesh,USFDA,Hepatitis C,Beacon,Gilead

  • Open Graph Meta Tags

    6
    • og:title
      US’ Gilead faces competition from Bangladesh’s Beacon pharma
    • og:description
      The challenger Beacon produces first generic version of Gileads newly launched Epclusa — a drug used to treat all types of Hepatitis C.
    • og:site_name
      The Economic Times
    • og:type
      website
    • og:url
      https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/articleshow/53407488.cms

  • Twitter Meta Tags

    13
    • twitter:card
      summary_large_image
    • twitter:site
      @EconomicTimes
    • twitter:url
      https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/articleshow/53407488.cms
    • twitter:title
      US’ Gilead faces competition from Bangladesh’s Beacon pharma
    • twitter:description
      The challenger Beacon produces first generic version of Gileads newly launched Epclusa — a drug used to treat all types of Hepatitis C.

  • Item Prop Meta Tags

    30
    • name
      US’ Gilead faces competition from Bangladesh’s Beacon pharma - The Economic Times
    • description
      The challenger Beacon produces first generic version of Gileads newly launched Epclusa — a drug used to treat all types of Hepatitis C.
    • image
      https://img.etimg.com/thumb/msid-53407488,width-1200,height-630,imgsize-377953,overlay-economictimes/articleshow.jpg
    • url
      /
    • name
      Home

  • Link Tags

    44
    • alternate
      https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/articleshow/53407488.cms
    • alternate
      android-app://com.et.reader.activities/etandroidapp/article/53407488
    • amphtml
      https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/amp_articleshow/53407488.cms
    • apple-touch-icon
      https://economictimes.indiatimes.com/thumb/width-120,height-120,msid-75267040/et.jpg
    • canonical
      https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/articleshow/53407488.cms

Links

300